Jintai Yu, MD, PhD (Precision Neurology)

Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China

Dr. Yu is currently an associate professor in the Department of Neurology, Qingdao Municipal Hospital, Qingdao University. He is the committee member of the Neurological Genetic Disease study group of the Chinese Neurological Society and a young committee member ofthe Chinese Behavior Medicine Society. Over the past years, his research interest has been focusing on (1) to investigate the genetics and biomarkers of Alzheimer’s disease; (2) to explore the pathogenesis and novel therapy of Alzheimer’s disease. Dr. Yu has been PIs of several grants funded by National Natural Science Foundation of China. He is currently also involving in several NIH sponsored large cohort consortiumsin Dr. Boxer’s lab in the field of Tauopathies and Frontotemporal Lober Degeneration in UCSF, such as the “Four Repeat Tauopathy Neuroimaging Initiative (4RTNI)”, and the “The Frontotemporal Lobar Degeneration Clinical Research Consortium (FLDCRC)”.

Dr. Jintai Yu is currently the senior editor of Journal of Alzheimer’s Disease, editor of American Journal of Neurodegenerative Disease, Molecular & Cellular Epilepsy, et al., and is the author of more than 150 peer review publications in the main scientific journals including: Annu Rev Neurosci, Trends Mol Med, Alzheimers Dement, Neuropsychopharmacology, J Neurol Neurosurg Psychiatry, Neurobiol Aging, Mol Neurobiol, Neuropharmacology, Br J Pharmacol, J Alzheimers Dis, et al.